These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19764891)

  • 1. Targeting SGK1 in diabetes.
    Lang F; Görlach A; Vallon V
    Expert Opin Ther Targets; 2009 Nov; 13(11):1303-11. PubMed ID: 19764891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and glucocorticoid inducible kinase, metabolic syndrome, inflammation, and tumor growth.
    Lang F; Stournaras C
    Hormones (Athens); 2013; 12(2):160-71. PubMed ID: 23933686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition.
    Lang F; Voelkl J
    Expert Opin Investig Drugs; 2013 Jun; 22(6):701-14. PubMed ID: 23506284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of SGK1 in the regulation of neuronal function.
    Lang F; Strutz-Seebohm N; Seebohm G; Lang UE
    J Physiol; 2010 Sep; 588(Pt 18):3349-54. PubMed ID: 20530112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterocyclic indazole derivatives as SGK1 inhibitors, WO2008138448.
    Lang F; Görlach A
    Expert Opin Ther Pat; 2010 Jan; 20(1):129-35. PubMed ID: 20021289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms.
    Lang F; Böhmer C; Palmada M; Seebohm G; Strutz-Seebohm N; Vallon V
    Physiol Rev; 2006 Oct; 86(4):1151-78. PubMed ID: 17015487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of ion channels by the serum- and glucocorticoid-inducible kinase SGK1.
    Lang F; Shumilina E
    FASEB J; 2013 Jan; 27(1):3-12. PubMed ID: 23012321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of transport across cell membranes by the serum- and glucocorticoid-inducible kinase SGK1.
    Lang F; Stournaras C; Alesutan I
    Mol Membr Biol; 2014 Feb; 31(1):29-36. PubMed ID: 24417516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SGK, renal function and hypertension.
    Lang F; Huang DY; Vallon V
    J Nephrol; 2010; 23 Suppl 16(0 16):S124-9. PubMed ID: 21170869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic insights into the role of serum-glucocorticoid kinase 1 in diabetic nephropathy: A systematic review.
    Noor S; Mohammad T; Ashraf GM; Farhat J; Bilgrami AL; Eapen MS; Sohal SS; Yadav DK; Hassan MI
    Int J Biol Macromol; 2021 Dec; 193(Pt A):562-573. PubMed ID: 34715204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Liters a Day Keep the Doctor Away? Considerations on the Pathophysiology of Suboptimal Fluid Intake in the Common Population.
    Lang F; Guelinckx I; Lemetais G; Melander O
    Kidney Blood Press Res; 2017; 42(3):483-494. PubMed ID: 28787716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the role of serum- and glucocorticoid-inducible kinase SGK1 in the regulation of renal function and blood pressure.
    Vallon V; Lang F
    Curr Opin Nephrol Hypertens; 2005 Jan; 14(1):59-66. PubMed ID: 15586017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal carcinoma cells--regulation of survival and growth by SGK1.
    Lang F; Perrotti N; Stournaras C
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1571-5. PubMed ID: 20541034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the epithelial Na+ channel by the mTORC2/SGK1 pathway.
    Lang F; Pearce D
    Nephrol Dial Transplant; 2016 Feb; 31(2):200-5. PubMed ID: 26163195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoids and serum- and glucocorticoid-inducible kinase 1 are potent regulators of CFTR in the native intestine: implications for stress-induced diarrhea.
    Ahsan MK; Figueroa-Hall L; Baratta V; Garcia-Milian R; Lam TT; Hoque K; Salas PJ; Ameen NA
    Am J Physiol Gastrointest Liver Physiol; 2020 Aug; 319(2):G121-G132. PubMed ID: 32567324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARgamma agonist pioglitazone.
    Artunc F; Sandulache D; Nasir O; Boini KM; Friedrich B; Beier N; Dicks E; Pötzsch S; Klingel K; Amann K; Blazer-Yost BL; Scholz W; Risler T; Kuhl D; Lang F
    Pflugers Arch; 2008 May; 456(2):425-36. PubMed ID: 18172605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phosphoinositide 3-kinase (PI3K)-serum- and glucocorticoid-inducible kinase 1 (SGK1) pathway promotes Kv7.1 channel surface expression by inhibiting Nedd4-2 protein.
    Andersen MN; Krzystanek K; Petersen F; Bomholtz SH; Olesen SP; Abriel H; Jespersen T; Rasmussen HB
    J Biol Chem; 2013 Dec; 288(52):36841-54. PubMed ID: 24214981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum- and glucocorticoid-inducible kinase 1 and the response to cell stress.
    Lang F; Stournaras C; Zacharopoulou N; Voelkl J; Alesutan I
    Cell Stress; 2018 Dec; 3(1):1-8. PubMed ID: 31225494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and Glucocorticoid Regulated Kinase 1 in Sodium Homeostasis.
    Lou Y; Zhang F; Luo Y; Wang L; Huang S; Jin F
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27517916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of glucose transporter SGLT1 by ubiquitin ligase Nedd4-2 and kinases SGK1, SGK3, and PKB.
    Dieter M; Palmada M; Rajamanickam J; Aydin A; Busjahn A; Boehmer C; Luft FC; Lang F
    Obes Res; 2004 May; 12(5):862-70. PubMed ID: 15166308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.